Genomes.io, the London-based startup using blockchain technology to give people ownership and control over their genomic data, arrives at the German Bundestag in Berlin for the kickoff of Tachyon 2.0 – the accelerator program run by leading blockchain company ConsenSys Ventures. Genomes.io acceptance into the accelerator follows a successful Crowdcube raise in 2018 which attracted investment from over 300 investors.
Genomes.io features as the only health technology company accepted into Tachyon 2.0 alongside 10 other companies from across the globe.
Tachyon 2.0 is focused on building new blockchain-enabled solutions and platforms across data privacy and identity, advanced encryption, healthcare, AI and IoT solutions, decentralized finance, microinsurance, and other sectors. It features programming time spent in global blockchain hubs of Berlin and San Francisco in which Genomes.io will benefit from meetings and lectures with prominent entrepreneurs, Ethereum developers, and venture capitalists — as well as access to ConsenSys’ vast and diverse network.
[perfectpullquote align=”full” bordertop=”false” cite=”Aldo de Pape, CEO of Genomes.io” link=”” color=”” class=”” size=””]”We are honored to have been invited to join the Tachyon 2.0 cohort. We believe the technical, industrial expertise and backing of ConsenSys will significantly bolster our efforts to power personalized medicine by building the Web 3.0 solution for the secure storage and private sharing of genomic data that gives ownership and control back to the individual.”[/perfectpullquote]
[perfectpullquote align=”full” bordertop=”false” cite=”Kavita Gupta, managing partner of ConsenSys Ventures” link=”” color=”” class=”” size=””]”We continue believing in providing support to promising entrepreneurs that need the accelerator format to refine their projects and ideas. With the backing of the ConsenSys and Ethereum ecosystems, we aim to provide all the necessary tool-kits for our entrepreneurs to succeed both in the short term and in the long run.”[/perfectpullquote]
